Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1976 Jul;34(1):14–19. doi: 10.1038/bjc.1976.115

Mechanisms of leucocyte migration inhibition by breast tumour cell fractions.

B M Jones
PMCID: PMC2025121  PMID: 952712

Abstract

Leucocyte migration inhibition by autologous breast tumour cell fractions was mediated by a soluble factor synthesized and released by mononuclear leucocytes and active against migrating granulocytes. This mechanism is similar to that previously described in respect to cell-mediated sensitivity to microbial antigens. Alternative mechanisms involving directly reactive granulocytes or cytophilic antibodies were rarely operative in the migration tests.

Full text

PDF
14

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amos H. E., Gurner B. W., Olds R. J., Coombs R. R. Passive sensitization of tissue cells. II. Ability of cytophilic antibody to render the migration of guinea pig peritoneal exudate cells inhibitable by antigen. Int Arch Allergy Appl Immunol. 1967;32(5):496–505. [PubMed] [Google Scholar]
  2. Andersen V., Bjerrum O., Bendixen G., Schiodt T., Dissing I. Effect of autologous mammary tumour extracts on human leukocyte migration in vitro. Int J Cancer. 1970 May 15;5(3):357–363. doi: 10.1002/ijc.2910050308. [DOI] [PubMed] [Google Scholar]
  3. Clausen J. E. Migration inhibitory effect of cell-free supernatants from tuberculin-stimulated cultures of human mononuclear leukocytes demonstrated by two-step MIF agarose assay. J Immunol. 1973 Feb;110(2):546–551. [PubMed] [Google Scholar]
  4. Cochran A. J., Jehn U. W., Gothoskar B. P. Cell-mediated immunity in malignant melanoma. Lancet. 1972 Jun 17;1(7764):1340–1341. doi: 10.1016/s0140-6736(72)91070-7. [DOI] [PubMed] [Google Scholar]
  5. Ellis R. J., Wernick G., Zabriskie J. B., Goldman L. I. Immunologic competence of regional lymph nodes in patients with breast cancer. Cancer. 1975 Mar;35(3):655–659. doi: 10.1002/1097-0142(197503)35:3<655::aid-cncr2820350318>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  6. Epstein L. B., Kreth H. W., Herzenberg L. A. Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens. Cell Immunol. 1974 Jun;12(3):407–421. doi: 10.1016/0008-8749(74)90097-5. [DOI] [PubMed] [Google Scholar]
  7. Fimmel P. J. Studies on leukocyte migration inhibiton: the role of E rosette-forming cells in specific antigen-induced inhibition of migration. J Immunol. 1975 Jul;115(1):135–138. [PubMed] [Google Scholar]
  8. Jones B. M., Connolly C. E., Isaacson P., Turner D. T., Turnbull A. R. Tumour-directed leucocyte migration inhibition in operable breast cancer: additional clinical correlations. Br J Cancer. 1976 Jul;34(1):94–96. doi: 10.1038/bjc.1976.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jones B. M., Turnbull A. R. Horizontal studies of cell mediated immune reactions to autologous tumour antigens in patients with operable mammary carcinoma. Br J Cancer. 1975 Sep;32(3):339–344. doi: 10.1038/bjc.1975.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jones B. M., Turnbull A. R. In vitro cellular immunity in mammary carcinoma. Br J Cancer. 1974 Apr;29(4):337–339. doi: 10.1038/bjc.1974.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kjaer M. In vitro demonstration of cellular hypersensitivity to tumour antigens by means of the leucocyte migration technique in patients with renal carcinoma. Eur J Cancer. 1974 Aug;10(8):523–531. doi: 10.1016/0014-2964(74)90077-2. [DOI] [PubMed] [Google Scholar]
  12. McCoy J. L., Jerome L. F., Dean J. H., Cannon G. B., Alford T. C., Doering T., Herberman R. B. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma. J Natl Cancer Inst. 1974 Jul;53(1):11–17. doi: 10.1093/jnci/53.1.11. [DOI] [PubMed] [Google Scholar]
  13. McCoy J. L., Jerome L. F., Dean J. H., Perlin E., Oldham R. K., Char D. H., Cohen M. H., Felix E. L., Herberman R. B. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. J Natl Cancer Inst. 1975 Jul;55(1):19–23. doi: 10.1093/jnci/55.1.19. [DOI] [PubMed] [Google Scholar]
  14. Packalén T., Wasserman J. Inhibition of migration of normal guinea pig blood leukocytes by homologous immune gamma 2-globulin in the presence of specific antigen. Int Arch Allergy Appl Immunol. 1971;41(5):790–796. doi: 10.1159/000230569. [DOI] [PubMed] [Google Scholar]
  15. Rocklin R. E., MacDermott R. P., Chess L., Schlossman S. F., David J. R. Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med. 1974 Nov 1;140(5):1303–1316. doi: 10.1084/jem.140.5.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rocklin R. E. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF). J Immunol. 1974 Apr;112(4):1461–1466. [PubMed] [Google Scholar]
  17. Segall A., Weiler O., Genin J., Lacour J., Lacour F. In vitro study of cellular immunity against autochthonous human cancer. Int J Cancer. 1972 Mar 15;9(2):417–425. doi: 10.1002/ijc.2910090221. [DOI] [PubMed] [Google Scholar]
  18. Senyk G., Hadley W. K. In vitro correlates of delayed hypersensitivity in man: ambiguity of polymorphonuclear neutrophils as indicator cells in leukocyte migration test. Infect Immun. 1973 Sep;8(3):370–380. doi: 10.1128/iai.8.3.370-380.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Soborg M., Bendixen G. Human lymphocyte migration as a parameter of hypersensitivity. Acta Med Scand. 1967 Feb;181(2):247–256. doi: 10.1111/j.0954-6820.1967.tb07255.x. [DOI] [PubMed] [Google Scholar]
  20. Soborg M. Interaction of human peripheral lymphocytes and granulocytes in the migration-inhibition reaction. Acta Med Scand. 1969 Mar;185(3):221–226. [PubMed] [Google Scholar]
  21. Wolberg W. H. Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers. Cancer Res. 1971 Jun;31(6):798–802. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES